Summary

The global meningococcal vaccines market size reached US$ 3.6 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 7.2 Billion by 2032, exhibiting a growth rate (CAGR) of 7.7% during 2024-2032.

Meningococcal vaccine refers to a biological substance administered for the prevention of meningitis, which is a contagious infection of the membranes surrounding the spinal cord and the brain. The three main kinds of meningococcal vaccines include conjugate, polysaccharide and subcapsular meningococcal vaccines. They are administered to infants, children and adults to immunize them against the invasive disease and target meningococcal bacteria A, B, C, W-135 and Y. Once the vaccine is administered, antibodies are formed to fight the bacteria and create an immune response to prevent the infection in the future.

The increasing prevalence of the meningococcal disease among young children and adolescents across the globe represents one of the key factors driving the growth of the market. Furthermore, the rising health consciousness among the masses and the adoption of routine immunization are providing a thrust to the market growth. Meningococcal vaccine aids in preventing the disease and minimizing the long-term effects, such as temporary or permanent deafness, loss of vision and motor skills, seizure and neurological damage. In line with this, governments of both developed and emerging economies are launching extensive public health programs while emphasizing on the immunization of special risk groups, such as tourists and military personnel, to contain the risks of infections. Additionally, various product innovations, such as the development of ready-to-use liquid formulations that do not require reconstitution, are also contributing to the market growth. Other factors, including extensive research and development (R&D) activities, along with improvements in the healthcare infrastructure, are anticipated to drive the market further.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global meningococcal vaccines market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on vaccine type, composition, vaccine serotype, distribution channel and end user.
Breakup by Vaccine Type:

• Conjugate
• Polysaccharide
• Subcapsular

Breakup by Composition:
• Mono Vaccines
• Combination Vaccines

Breakup by Vaccine Serotype:
• MenACWY
• MenB & Manic
• MenC
• MenA
• MenAC
• Others

Breakup by Distribution Channel:
• Hospital Pharmacies
• Retail Pharmacies
• Institutional Sales
• Others

Breakup by End User:
• Pediatric
• Adult

Breakup by Region:

• North America
o United States
o Canada
• Asia Pacific
o China
o Japan
o India
o South Korea
o Australia
o Indonesia
o Others
• Europe
o Germany
o France
o United Kingdom
o Italy
o Spain
o Russia
o Others
• Latin America
o Brazil
o Mexico
o Others
• Middle East and Africa
Competitive Landscape:
The report has also analysed the competitive landscape of the market with some of the key players being GlaxoSmithKline Plc, Hualan Biological Engineering Inc., Incepta Pharmaceuticals Limited, Novartis AG, Pfizer Inc., Sanofi S.A., Serum Institute of India Ltd. and Walvax Biotechnology Co. Ltd.

Key Questions Answered in This Report:
• How has the global meningococcal vaccines market performed so far and how will it perform in the coming years?
• What has been the impact of COVID-19 on the global meningococcal vaccines market?
• What are the key regional markets?
• What is the breakup of the market based on the vaccine type?
• What is the breakup of the market based on the composition?
• What is the breakup of the market based on the vaccine serotype?
• What is the breakup of the market based on the distribution channel?
• What is the breakup of the market based on the end user?
• What are the various stages in the value chain of the industry?
• What are the key driving factors and challenges in the industry?
• What is the structure of the global meningococcal vaccines market and who are the key players?
• What is the degree of competition in the industry?

ページTOPに戻る

Table of Contents

1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Meningococcal Vaccines Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Vaccine Type
6.1 Conjugate
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Polysaccharide
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Subcapsular
6.3.1 Market Trends
6.3.2 Market Forecast
7 Market Breakup by Composition
7.1 Mono Vaccines
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Combination Vaccines
7.2.1 Market Trends
7.2.2 Market Forecast
8 Market Breakup by Vaccine Serotype
8.1 MenACWY
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 MenB & Manic
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 MenC
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 MenA
8.4.1 Market Trends
8.4.2 Market Forecast
8.5 MenAC
8.5.1 Market Trends
8.5.2 Market Forecast
8.6 Others
8.6.1 Market Trends
8.6.2 Market Forecast
9 Market Breakup by Distribution Channel
9.1 Hospital Pharmacies
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Retail Pharmacies
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Institutional Sales
9.3.1 Market Trends
9.3.2 Market Forecast
9.4 Others
9.4.1 Market Trends
9.4.2 Market Forecast
10 Market Breakup by End User
10.1 Pediatric
10.1.1 Market Trends
10.1.2 Market Forecast
10.2 Adult
10.2.1 Market Trends
10.2.2 Market Forecast
11 Market Breakup by Region
11.1 North America
11.1.1 United States
11.1.1.1 Market Trends
11.1.1.2 Market Forecast
11.1.2 Canada
11.1.2.1 Market Trends
11.1.2.2 Market Forecast
11.2 Asia Pacific
11.2.1 China
11.2.1.1 Market Trends
11.2.1.2 Market Forecast
11.2.2 Japan
11.2.2.1 Market Trends
11.2.2.2 Market Forecast
11.2.3 India
11.2.3.1 Market Trends
11.2.3.2 Market Forecast
11.2.4 South Korea
11.2.4.1 Market Trends
11.2.4.2 Market Forecast
11.2.5 Australia
11.2.5.1 Market Trends
11.2.5.2 Market Forecast
11.2.6 Indonesia
11.2.6.1 Market Trends
11.2.6.2 Market Forecast
11.2.7 Others
11.2.7.1 Market Trends
11.2.7.2 Market Forecast
11.3 Europe
11.3.1 Germany
11.3.1.1 Market Trends
11.3.1.2 Market Forecast
11.3.2 France
11.3.2.1 Market Trends
11.3.2.2 Market Forecast
11.3.3 United Kingdom
11.3.3.1 Market Trends
11.3.3.2 Market Forecast
11.3.4 Italy
11.3.4.1 Market Trends
11.3.4.2 Market Forecast
11.3.5 Spain
11.3.5.1 Market Trends
11.3.5.2 Market Forecast
11.3.6 Russia
11.3.6.1 Market Trends
11.3.6.2 Market Forecast
11.3.7 Others
11.3.7.1 Market Trends
11.3.7.2 Market Forecast
11.4 Latin America
11.4.1 Brazil
11.4.1.1 Market Trends
11.4.1.2 Market Forecast
11.4.2 Mexico
11.4.2.1 Market Trends
11.4.2.2 Market Forecast
11.4.3 Others
11.4.3.1 Market Trends
11.4.3.2 Market Forecast
11.5 Middle East and Africa
11.5.1 Market Trends
11.5.2 Market Breakup by Country
11.5.3 Market Forecast
12 SWOT Analysis
12.1 Overview
12.2 Strengths
12.3 Weaknesses
12.4 Opportunities
12.5 Threats
13 Value Chain Analysis
14 Porters Five Forces Analysis
14.1 Overview
14.2 Bargaining Power of Buyers
14.3 Bargaining Power of Suppliers
14.4 Degree of Competition
14.5 Threat of New Entrants
14.6 Threat of Substitutes
15 Price Analysis
16 Competitive Landscape
16.1 Market Structure
16.2 Key Players
16.3 Profiles of Key Players
16.3.1 GlaxoSmithKline Plc
16.3.1.1 Company Overview
16.3.1.2 Product Portfolio
16.3.1.3 Financials
16.3.1.4 SWOT Analysis
16.3.2 Hualan Biological Engineering Inc.
16.3.2.1 Company Overview
16.3.2.2 Product Portfolio
16.3.2.3 Financials
16.3.3 Incepta Pharmaceuticals Limited
16.3.3.1 Company Overview
16.3.3.2 Product Portfolio
16.3.4 Novartis AG
16.3.4.1 Company Overview
16.3.4.2 Product Portfolio
16.3.4.3 Financials
16.3.4.4 SWOT Analysis
16.3.5 Pfizer Inc.
16.3.5.1 Company Overview
16.3.5.2 Product Portfolio
16.3.5.3 Financials
16.3.5.4 SWOT Analysis
16.3.6 Sanofi S.A.
16.3.6.1 Company Overview
16.3.6.2 Product Portfolio
16.3.6.3 Financials
16.3.6.4 SWOT Analysis
16.3.7 Serum Institute of India Ltd.
16.3.7.1 Company Overview
16.3.7.2 Product Portfolio
16.3.8 Walvax Biotechnology Co. Ltd.
16.3.8.1 Company Overview
16.3.8.2 Product Portfolio
16.3.8.3 Financials
List of Figures
Figure 1: Global: Meningococcal Vaccines Market: Major Drivers and Challenges
Figure 2: Global: Meningococcal Vaccines Market: Sales Value (in Billion US$), 2018-2023
Figure 3: Global: Meningococcal Vaccines Market: Breakup by Vaccine Type (in %), 2023
Figure 4: Global: Meningococcal Vaccines Market: Breakup by Composition (in %), 2023
Figure 5: Global: Meningococcal Vaccines Market: Breakup by Vaccine Serotype (in %), 2023
Figure 6: Global: Meningococcal Vaccines Market: Breakup by Distribution Channel (in %), 2023
Figure 7: Global: Meningococcal Vaccines Market: Breakup by End User (in %), 2023
Figure 8: Global: Meningococcal Vaccines Market: Breakup by Region (in %), 2023
Figure 9: Global: Meningococcal Vaccines Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 10: Global: Meningococcal Vaccines (Conjugate) Market: Sales Value (in Million US$), 2018 & 2023
Figure 11: Global: Meningococcal Vaccines (Conjugate) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 12: Global: Meningococcal Vaccines (Polysaccharide) Market: Sales Value (in Million US$), 2018 & 2023
Figure 13: Global: Meningococcal Vaccines (Polysaccharide) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 14: Global: Meningococcal Vaccines (Subcapsular) Market: Sales Value (in Million US$), 2018 & 2023
Figure 15: Global: Meningococcal Vaccines (Subcapsular) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 16: Global: Meningococcal Vaccines (Mono Vaccines) Market: Sales Value (in Million US$), 2018 & 2023
Figure 17: Global: Meningococcal Vaccines (Mono Vaccines) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 18: Global: Meningococcal Vaccines (Combination Vaccines) Market: Sales Value (in Million US$), 2018 & 2023
Figure 19: Global: Meningococcal Vaccines (Combination Vaccines) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 20: Global: Meningococcal Vaccines (MenACWY) Market: Sales Value (in Million US$), 2018 & 2023
Figure 21: Global: Meningococcal Vaccines (MenACWY) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 22: Global: Meningococcal Vaccines (MenB & Manic) Market: Sales Value (in Million US$), 2018 & 2023
Figure 23: Global: Meningococcal Vaccines (MenB & Manic) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 24: Global: Meningococcal Vaccines (MenC) Market: Sales Value (in Million US$), 2018 & 2023
Figure 25: Global: Meningococcal Vaccines (MenC) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 26: Global: Meningococcal Vaccines (MenA) Market: Sales Value (in Million US$), 2018 & 2023
Figure 27: Global: Meningococcal Vaccines (MenA) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 28: Global: Meningococcal Vaccines (MenAC) Market: Sales Value (in Million US$), 2018 & 2023
Figure 29: Global: Meningococcal Vaccines (MenAC) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 30: Global: Meningococcal Vaccines (Other Vaccine Serotypes) Market: Sales Value (in Million US$), 2018 & 2023
Figure 31: Global: Meningococcal Vaccines (Other Vaccine Serotypes) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 32: Global: Meningococcal Vaccines (Hospital Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
Figure 33: Global: Meningococcal Vaccines (Hospital Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 34: Global: Meningococcal Vaccines (Retail Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
Figure 35: Global: Meningococcal Vaccines (Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 36: Global: Meningococcal Vaccines (Institutional Sales) Market: Sales Value (in Million US$), 2018 & 2023
Figure 37: Global: Meningococcal Vaccines (Institutional Sales) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 38: Global: Meningococcal Vaccines (Other Distribution Channels) Market: Sales Value (in Million US$), 2018 & 2023
Figure 39: Global: Meningococcal Vaccines (Other Distribution Channels) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 40: Global: Meningococcal Vaccines (Pediatric) Market: Sales Value (in Million US$), 2018 & 2023
Figure 41: Global: Meningococcal Vaccines (Pediatric) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 42: Global: Meningococcal Vaccines (Adult) Market: Sales Value (in Million US$), 2018 & 2023
Figure 43: Global: Meningococcal Vaccines (Adult) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 44: North America: Meningococcal Vaccines Market: Sales Value (in Million US$), 2018 & 2023
Figure 45: North America: Meningococcal Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 46: United States: Meningococcal Vaccines Market: Sales Value (in Million US$), 2018 & 2023
Figure 47: United States: Meningococcal Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 48: Canada: Meningococcal Vaccines Market: Sales Value (in Million US$), 2018 & 2023
Figure 49: Canada: Meningococcal Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 50: Asia Pacific: Meningococcal Vaccines Market: Sales Value (in Million US$), 2018 & 2023
Figure 51: Asia Pacific: Meningococcal Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 52: China: Meningococcal Vaccines Market: Sales Value (in Million US$), 2018 & 2023
Figure 53: China: Meningococcal Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 54: Japan: Meningococcal Vaccines Market: Sales Value (in Million US$), 2018 & 2023
Figure 55: Japan: Meningococcal Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 56: India: Meningococcal Vaccines Market: Sales Value (in Million US$), 2018 & 2023
Figure 57: India: Meningococcal Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 58: South Korea: Meningococcal Vaccines Market: Sales Value (in Million US$), 2018 & 2023
Figure 59: South Korea: Meningococcal Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 60: Australia: Meningococcal Vaccines Market: Sales Value (in Million US$), 2018 & 2023
Figure 61: Australia: Meningococcal Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 62: Indonesia: Meningococcal Vaccines Market: Sales Value (in Million US$), 2018 & 2023
Figure 63: Indonesia: Meningococcal Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 64: Others: Meningococcal Vaccines Market: Sales Value (in Million US$), 2018 & 2023
Figure 65: Others: Meningococcal Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 66: Europe: Meningococcal Vaccines Market: Sales Value (in Million US$), 2018 & 2023
Figure 67: Europe: Meningococcal Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 68: Germany: Meningococcal Vaccines Market: Sales Value (in Million US$), 2018 & 2023
Figure 69: Germany: Meningococcal Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 70: France: Meningococcal Vaccines Market: Sales Value (in Million US$), 2018 & 2023
Figure 71: France: Meningococcal Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 72: United Kingdom: Meningococcal Vaccines Market: Sales Value (in Million US$), 2018 & 2023
Figure 73: United Kingdom: Meningococcal Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 74: Italy: Meningococcal Vaccines Market: Sales Value (in Million US$), 2018 & 2023
Figure 75: Italy: Meningococcal Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 76: Spain: Meningococcal Vaccines Market: Sales Value (in Million US$), 2018 & 2023
Figure 77: Spain: Meningococcal Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 78: Russia: Meningococcal Vaccines Market: Sales Value (in Million US$), 2018 & 2023
Figure 79: Russia: Meningococcal Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 80: Others: Meningococcal Vaccines Market: Sales Value (in Million US$), 2018 & 2023
Figure 81: Others: Meningococcal Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 82: Latin America: Meningococcal Vaccines Market: Sales Value (in Million US$), 2018 & 2023
Figure 83: Latin America: Meningococcal Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 84: Brazil: Meningococcal Vaccines Market: Sales Value (in Million US$), 2018 & 2023
Figure 85: Brazil: Meningococcal Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 86: Mexico: Meningococcal Vaccines Market: Sales Value (in Million US$), 2018 & 2023
Figure 87: Mexico: Meningococcal Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 88: Others: Meningococcal Vaccines Market: Sales Value (in Million US$), 2018 & 2023
Figure 89: Others: Meningococcal Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 90: Middle East and Africa: Meningococcal Vaccines Market: Sales Value (in Million US$), 2018 & 2023
Figure 91: Middle East and Africa: Meningococcal Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 92: Global: Meningococcal Vaccines Industry: SWOT Analysis
Figure 93: Global: Meningococcal Vaccines Industry: Value Chain Analysis
Figure 94: Global: Meningococcal Vaccines Industry: Porter’s Five Forces Analysis
List of Tables
Table 1: Global: Meningococcal Vaccines Market: Key Industry Highlights, 2023 and 2032
Table 2: Global: Meningococcal Vaccines Market Forecast: Breakup by Vaccine Type (in Million US$), 2024-2032
Table 3: Global: Meningococcal Vaccines Market Forecast: Breakup by Composition (in Million US$), 2024-2032
Table 4: Global: Meningococcal Vaccines Market Forecast: Breakup by Vaccine Serotype (in Million US$), 2024-2032
Table 5: Global: Meningococcal Vaccines Market Forecast: Breakup by Distribution Channel (in Million US$), 2024-2032
Table 6: Global: Meningococcal Vaccines Market Forecast: Breakup by End User (in Million US$), 2024-2032
Table 7: Global: Meningococcal Vaccines Market Forecast: Breakup by Region (in Million US$), 2024-2032
Table 8: Global: Meningococcal Vaccines Market: Competitive Structure
Table 9: Global: Meningococcal Vaccines Market: Key Players